Difficulty: Medium
Average Score: 85%
Practice
A 68-year-old man with a 6-month history of progressive pill-rolling tremors of the hands, urinary incontinence, and cogwheel rigidity presents to his primary care physician for evaluation. Physical examination confirms the earlier findings. Which of the following is a therapeutic goal for this condition?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Antagonizing the excitatory effect of cholinergic neurons. The patient is presenting with symptoms suggestive of Parkinson's disease, a neurodegenerative disorder characterized by a deficiency of dopamine in the brain. Antagonizing the excitatory effect of cholinergic neurons can help rebalance the neurotransmitter levels in the brain by reducing the overactivity of acetylcholine, which is elevated in Parkinson's disease.
Option B) Dynamic physical and occupational therapy, while beneficial for improving mobility and quality of life in Parkinson's patients, does not address the underlying neurotransmitter imbalance in the brain.
Option C) Lower concentrations of CNS dopamine is contrary to the therapeutic goal in Parkinson's disease, where the primary issue is a deficiency of dopamine.
Option D) Restore dopamine concentration in the cerebellum is not accurate as Parkinson's disease primarily affects the substantia nigra in the brain, not the cerebellum.
Educationally, it is crucial to understand the pathophysiology of Parkinson's disease and the role of neurotransmitters like dopamine and acetylcholine in motor function. Pharmacological interventions aim to restore the balance of these neurotransmitters to alleviate symptoms and slow disease progression. Understanding the rationale behind each treatment option is essential for providing effective care to patients with neurological disorders like Parkinson's disease.
Option B) Dynamic physical and occupational therapy, while beneficial for improving mobility and quality of life in Parkinson's patients, does not address the underlying neurotransmitter imbalance in the brain.
Option C) Lower concentrations of CNS dopamine is contrary to the therapeutic goal in Parkinson's disease, where the primary issue is a deficiency of dopamine.
Option D) Restore dopamine concentration in the cerebellum is not accurate as Parkinson's disease primarily affects the substantia nigra in the brain, not the cerebellum.
Educationally, it is crucial to understand the pathophysiology of Parkinson's disease and the role of neurotransmitters like dopamine and acetylcholine in motor function. Pharmacological interventions aim to restore the balance of these neurotransmitters to alleviate symptoms and slow disease progression. Understanding the rationale behind each treatment option is essential for providing effective care to patients with neurological disorders like Parkinson's disease.